Filed before 2025Filed 19 March 2019
Faraday Pharmaceuticals, Inc. raised $5M
Faraday Pharmaceuticals, Inc., a pharmaceuticals company based in Seattle, WA, raised $5M in a new debt round, according to a filing dated 19 March 2019.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 19 March 2019
- Round
- Debt round
- Amount sold
- $5M
- Offering size
- $10M
- Investors so far
- 7
- Based in
- Seattle, WA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 40% of the 1,781 tracked raises with an amount filed in 2019, and than 12% of the 33 in pharmaceuticals.
Faraday Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 7 Nov 2022 | New filing | $52.8M | Another raise |
| 12 Sep 2019 | New filing | $25.1M | Another raise |
| 19 Mar 2019 | New filing | $5M | This raise |
| 23 Jul 2014 | New filing | $3.66M | Not tracked |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.